Inotiv, Inc. (NOTVQ) vs ProPhase Labs, Inc. (PRPH)
Inotiv, Inc. and ProPhase Labs, Inc. are both Diagnostics & Research companies. Inotiv, Inc. is the larger, with a market value of $2.8M against $1.2M — 2.4× the size. Inotiv, Inc. grew revenue faster over the last twelve months: 5.61% against −43.5%. Inotiv, Inc. has the higher net margin (−17.1% vs −717.4%) and the higher return on invested capital (−6.19% vs −387.3%). Across the 17 metrics below, Inotiv, Inc. leads on 13 and ProPhase Labs, Inc. on 4.
Valuation
Profitability
| Metric | NOTVQ | PRPH | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 22.94% | 16.38% | 50.89% |
| Operating margin | (9.48%) | (498.73%) | (8.57%) |
| Net margin | (17.14%) | (717.43%) | (6.37%) |
| Free cash flow margin | (1.95%) | (175.22%) | 0.00% |
| Return on equity | (74.09%) | (543.95%) | (2.92%) |
| Return on assets | (11.85%) | (45.53%) | (6.71%) |
| Return on invested capital | (6.19%) | (387.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack